Finance

Lists
Why is 6541 down 2,89%?
Dive Deeper
6541:TPE
Tanvex Biopharma Inc
26,90 NT$
-2,89%
(-0,80) 1D
5 նոյ, 13:30:02 GMT+8  ·   TWD
All symbols
SymbolPriceChange% Change
Generating top insights for 6541...
Open
28,10 NT$
High
28,80 NT$
Low
26,85 NT$
Mkt. cap
7,13 մլրդ
Avg. vol.
477,19 հզր
Volume
606,27 հզր
52-wk high
65,50 NT$
52-wk low
26,05 NT$
EPS
-5,56 NT$
Shares outstanding
242,67 մլն
No. of employees
215
Open
28,10 NT$
High
28,80 NT$
Low
26,85 NT$
Mkt. cap
7,13 մլրդ
Avg. vol.
477,19 հզր
Volume
606,27 հզր
52-wk high
65,50 NT$
52-wk low
26,05 NT$
EPS
-5,56 NT$
Shares outstanding
242,67 մլն
No. of employees
215
News stories
From web sources and news partners
About Tanvex Biopharma Inc
CEO-
Employees215
Founded2011
Headquarters-
Sector-
Industry-
Websitetanvex.com
Previous reportsAll values in TWD
Loading Previous Earnings...
Revenue
Net income
All values in TWD
2025 թ. սեպ
2025 թ. դեկ
2026 թ. մրտ
2026 թ. հնս
Revenue
125,34 մլն
178,95 մլն
132,83 մլն
220,44 մլն
Cost of goods sold
287,65 մլն
422,66 մլն
399,36 մլն
446,37 մլն
Cost of revenue
287,65 մլն
422,66 մլն
399,36 մլն
446,37 մլն
Research and development expenses
19,27 մլն
13,26 մլն
24,24 մլն
19,86 մլն
Total research and development expenses
-
-
-
-
Selling, general, and admin expenses
104,56 մլն
104,26 մլն
108,51 մլն
121,17 մլն
Operating expense
123,98 մլն
129,86 մլն
133,70 մլն
141,15 մլն
Total operating expenses
411,63 մլն
552,52 մլն
533,06 մլն
587,52 մլն
Operating income
-286,29 մլն
-373,57 մլն
-400,23 մլն
-367,07 մլն
Other non operating income
-372,00 հզր
44,99 մլն
188,00 հզր
418,00 հզր
EBT including unusual items
-273,50 մլն
-420,53 մլն
-388,70 մլն
-382,53 մլն
EBT excluding unusual items
-294,27 մլն
-305,62 մլն
-388,70 մլն
-382,53 մլն
Income tax expense
-
3,00 հզր
27,00 հզր
1,00 հզր
Effective tax rate
-
-
-0,01%
-
Other operating expenses
-
-
-
-
Net income
-273,50 մլն
-420,54 մլն
-388,72 մլն
-382,53 մլն
Net profit margin
-218,21%
-235,00%
-292,65%
-173,53%
Earnings per share
-
-
-
-
Interest and investment income
7,83 մլն
11,66 մլն
6,03 մլն
5,01 մլն
Interest expense
-11,41 մլն
-11,31 մլն
-11,70 մլն
-16,53 մլն
Net interest expenses
-3,58 մլն
354,00 հզր
-5,67 մլն
-11,52 մլն
Depreciation and amortization charges
-
-
-
-
EBITDA
-243,08 մլն
-370,64 մլն
-357,68 մլն
-326,85 մլն
Gain or loss from assets sale
-21,83 մլն
62,12 մլն
-
-
Upcoming events
AI content may include mistakes. Learn more
HelpSend feedbackPrivacyTermsDisclaimer
Google Apps